Perrigo Co PLC (PRGO)

43.29 -0.13  -0.30% NYSE Jan 22, 20:00 USD
View Full Chart
Price Chart
View All PRGO News

News

View All Events

Events

Date Type Description
02/26/2021 Earnings Perrigo Co PLC Fourth Quarter Earnings for 2020 Release
02/26/2021 08:30 EST Misc Perrigo Co PLC Fourth Quarter Earnings Conference Call for 2020
11/25/2020 Dividends Amount: 0.225, Declared Date: Oct 22 2020, Pay Date: Dec 15 2020
11/04/2020 Earnings Perrigo Co PLC Third Quarter Earnings Result for 2020
11/04/2020 16:30 EST Misc Perrigo Co PLC Third Quarter Earnings Conference Call for 2020
08/27/2020 Dividends Amount: 0.225, Declared Date: Jul 29 2020, Pay Date: Sep 15 2020
08/05/2020 09:00 EDT Misc Perrigo Co PLC Second Quarter Earnings Conference Call for 2020
08/05/2020 Earnings Perrigo Co PLC Second Quarter Earnings Result for 2020
05/28/2020 Dividends Amount: 0.225, Declared Date: May 05 2020, Pay Date: Jun 16 2020
05/06/2020 11:30 IST Misc Perrigo Co PLC Annual General Meeting for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.perrigo.com
  • Investor Relations URL: http://perrigo.investorroom.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Feb. 26, 2021
  • Last Earnings Release: Nov. 04, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Nov. 25, 2020
  • Description: Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to OTC and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.

Top Fund Holders

Symbol Name Weighting
XPH SPDR® S&P Pharmaceuticals ETF 3.72%
FTXH First Trust Nasdaq Pharmaceuticals ETF 3.37%
SSHVX Sound Shore Institutional 3.23%
CSINX Centerstone International C 2.82%
TMCTX Touchstone Mid Cap Z 2.37%
PILL Direxion Daily Phrmctcl&MdclBl3XShrsETF 2.24%
IHE iShares US Pharmaceuticals ETF 2.10%
CENNX Centerstone Investors C 2.07%
PPH VanEck Vectors Pharmaceutical ETF 2.05%
GRX Gabelli Health & Wellness 1.60%
FPHAX Fidelity® Select Pharmaceuticals Port 1.31%
DTMVX DFA Tax-Managed US Targeted Value 0.43%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.